|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,430,000,000 |
Market
Cap: |
110.27(B) |
Last
Volume: |
6,919,020 |
Avg
Vol: |
8,403,954 |
52
Week Range: |
$48.64 - $76.12 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 297 |
Guru Rank Value : 4.1 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) ![](../../images/information.jpg) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
319,019 |
515,317 |
1,014,661 |
2,126,174 |
Total Sell Value |
$23,643,548 |
$35,409,189 |
$61,747,133 |
$111,248,213 |
Total People Sold |
9 |
10 |
11 |
13 |
Total Sell Transactions |
15 |
27 |
45 |
80 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2023-12-29 |
4 |
AS |
$57.50 |
$4,711,550 |
D/D |
(81,940) |
174,241 |
|
27% |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2023-12-29 |
4 |
OE |
$16.31 |
$949,063 |
D/D |
58,189 |
256,181 |
|
- |
|
Carruthers Wendy |
EVP, Human Resources |
|
2023-12-15 |
4 |
AS |
$55.61 |
$649,075 |
D/D |
(11,672) |
41,269 |
|
30% |
|
Carruthers Wendy |
EVP, Human Resources |
|
2023-12-15 |
4 |
OE |
$13.08 |
$94,973 |
D/D |
6,409 |
52,941 |
|
- |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2023-12-06 |
4 |
AS |
$55.03 |
$19,426 |
D/D |
(353) |
56,588 |
|
23% |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2023-12-03 |
4 |
D |
$56.14 |
$16,617 |
D/D |
(296) |
56,941 |
|
- |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2023-12-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
649 |
57,237 |
|
- |
|
Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
|
2023-11-20 |
4 |
AS |
$54.06 |
$447,509 |
D/D |
(8,278) |
6,977 |
|
24% |
|
Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
|
2023-11-20 |
4 |
OE |
$17.26 |
$66,606 |
D/D |
3,859 |
15,255 |
|
- |
|
Carruthers Wendy |
EVP, Human Resources |
|
2023-11-15 |
4 |
AS |
$54.17 |
$632,269 |
D/D |
(11,671) |
46,532 |
|
27% |
|
Carruthers Wendy |
EVP, Human Resources |
|
2023-11-15 |
4 |
OE |
$13.08 |
$94,954 |
D/D |
6,408 |
58,203 |
|
- |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2023-11-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,000 |
56,588 |
|
- |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2023-11-06 |
4 |
AS |
$52.51 |
$5,951,983 |
D/D |
(113,356) |
1,498,922 |
|
27% |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2023-11-06 |
4 |
OE |
$13.08 |
$1,662,527 |
D/D |
113,356 |
1,612,278 |
|
- |
|
Carruthers Wendy |
EVP, Human Resources |
|
2023-10-16 |
4 |
AS |
$49.79 |
$581,063 |
D/D |
(11,671) |
51,795 |
|
33% |
|
Carruthers Wendy |
EVP, Human Resources |
|
2023-10-16 |
4 |
OE |
$13.08 |
$94,954 |
D/D |
6,408 |
63,466 |
|
- |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2023-10-09 |
4 |
AS |
$52.09 |
$5,904,481 |
D/D |
(113,355) |
1,498,922 |
|
26% |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2023-10-09 |
4 |
OE |
$13.08 |
$1,662,514 |
D/D |
113,355 |
1,612,277 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2023-09-20 |
4 |
AS |
$55.00 |
$872,685 |
D/D |
(15,867) |
197,992 |
|
14% |
|
Carruthers Wendy |
EVP, Human Resources |
|
2023-09-15 |
4 |
AS |
$53.95 |
$629,694 |
D/D |
(11,671) |
57,058 |
|
15% |
|
Carruthers Wendy |
EVP, Human Resources |
|
2023-09-15 |
4 |
OE |
$13.08 |
$94,954 |
D/D |
6,408 |
68,729 |
|
- |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2023-09-12 |
4 |
AS |
$53.91 |
$6,110,447 |
D/D |
(113,355) |
1,498,922 |
|
14% |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2023-09-12 |
4 |
OE |
$13.08 |
$1,662,514 |
D/D |
113,355 |
1,612,277 |
|
- |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2023-08-29 |
4 |
AS |
$54.50 |
$253,811 |
D/D |
(4,657) |
60,588 |
|
7% |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2023-08-28 |
4 |
AS |
$53.14 |
$742,419 |
D/D |
(13,971) |
65,245 |
|
8% |
|
2527 Records found
|
|
Page 7 of 102 |
|
|